Literature DB >> 6743832

IgG therapy in systemic lupus erythematosus--two case reports.

G Gaedicke, W M Teller, E Kohne, R Dopfer, D Niethammer.   

Abstract

Two paediatric patients with systemic lupus erythematosus were treated with immunoglobulin G (IgG). In the first case treatment resulted in regression of the most acute symptoms and a long remission was achieved. In the second patient, who was treated during the chronic stage of the disease, there was no significant effect on the course of the SLE.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6743832     DOI： 10.1007/BF00319968

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


  6 in total

1.  Plasmapheresis: a pediatric perspective.

Authors:  B H Singsen
Journal:  J Pediatr       Date:  1981-02       Impact factor: 4.406

Review 2.  The treatment of SLE: the case of conservative management.

Authors:  G R Hughes
Journal:  Clin Rheum Dis       Date:  1982-04

Review 3.  Lupus in childhood.

Authors:  J Schaller
Journal:  Clin Rheum Dis       Date:  1982-04

4.  Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.

Authors:  J Fehr; V Hofmann; U Kappeler
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

5.  Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980.

Authors:  D J Wallace; T E Podell; J M Weiner; M B Cox; J R Klinenberg; S Forouzesh; E L Dubois
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

6.  Systemic lupus erythematosus--survival patterns. Experience with 609 patients.

Authors:  D J Wallace; T Podell; J Weiner; J R Klinenberg; S Forouzesh; E L Dubois
Journal:  JAMA       Date:  1981-03-06       Impact factor: 56.272
  6 in total
  6 in total

Review 1.  Immunomodulation of autoimmune diseases by high-dose intravenous immunoglobulins.

Authors:  L Rauova; J Rovensky; Y Shoenfeld
Journal:  Springer Semin Immunopathol       Date:  2001-12

2.  Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin.

Authors:  N Kondo; T Ozawa; K Mushiake; F Motoyoshi; T Kameyama; K Kasahara; H Kaneko; M Yamashina; Y Kato; T Orii
Journal:  J Clin Immunol       Date:  1991-05       Impact factor: 8.317

Review 3.  Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders.

Authors:  S A Schwartz
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

4.  Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis.

Authors:  L Cook; J F Howard; J D Folds
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

Review 5.  Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.

Authors:  S C Jordan; M Toyoda
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  Detection and purification of antiidiotypic antibody against anti-DNA in intravenous immune globulin.

Authors:  M J Evans; R Suenaga; N I Abdou
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.